In this interview with naturopathic oncology specialist Adam Kerievsky, ND, LAc, FABNO, we discuss the risk factors for triple-negative breast cancer, the treatment challenges it poses for practitioners, and complementary therapies that may benefit patients battling this cancer.
Abstracts & Commentary
A groundbreaking study recently suggested that low levels of insulin-like growth factor-1 (IGF-1) may predict life expectancy in exceptionally long-lived individuals.
This cross-sectional analysis, comparing mental health status with neighborhood green space, found that green space significantly reduced 3 measures of depression according to participant responses to the Depression, Anxiety and Stress Scale.
Lymphedema affects many breast cancer patients. In this randomized trial, complete congestion therapy with a focus on manual lymph drainage was tested vs the use of compression garments to reduce lymphedema in 95 women being treated for breast cancer.
In a recent study, Epstein Barr virus patients who received intravenous vitamin C demonstrated decreased levels of antigens in the acute state of disease and alleviation of symptoms of the infection.
This review summarizes the pathophysiological connection of galectin-3 and cancer presently in the literature, as well as the potential clinical value of galectin-3 as a prognostic oncology biomarker. Based on the preliminary data, the galectin-3 assay could become a contributing tool to help clinicians monitor treatment response and tumor progression, but further clinical studies evaluating galectin-3 levels and cancer progression are warranted.
First published in 1996, this book aims to help students easily understand key concepts in evidence-based medicine and explain the logic and methodology of this approach. This year marks the publication of the fifth edition of the book, which has become a core textbook in medical schools around the world.